Retsema J et al. |
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2449865
|
Wondrack L et al. |
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849266
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Bohte R et al. |
Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593024
|
Beringer P et al. |
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304166
|
Ulrich M et al. |
Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304181
|
Vallée E et al. |
Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324644
|
Merchan LM et al. |
Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25385115
|
Mertens JC et al. |
Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324645
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Bonnet M and Van der Auwera P |
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329619
|
Koletar SL et al. |
Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582873
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Koetsveld J et al. |
Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28674060
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Ng LK et al. |
Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183262
|
Prunier AL et al. |
Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183270
|
Binet R and Maurelli AT |
Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17908942
|
Collins SA et al. |
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27919896
|
Walsh M et al. |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:3038010
|
Turcinov D et al. |
Failure of azithromycin in treatment of Brill-Zinsser disease. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817744
|
Tsitsika A et al. |
Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817749
|
Bin XX et al. |
Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817751
|
Pacifico L et al. |
Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849215
|
Galarza PG et al. |
New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20123998
|
Jaruratanasirikul S et al. |
Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851625
|
Marvig RL et al. |
Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22644032
|
Ohtani H et al. |
Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991836
|
Cigana C et al. |
Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17210769
|
Farrell DJ et al. |
Results from the Solithromycin International Surveillance Program (2014). |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044551
|
Chinh NT et al. |
A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858343
|
Miltner EC and Bermudez LE |
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858369
|
Sugimura M et al. |
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18676884
|
Liu P et al. |
Comparison of azithromycin pharmacokinetics following single oral doses of extended-release and immediate-release formulations in children with acute otitis media. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21859932
|
Shima K et al. |
Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23478971
|
Bermudez LE et al. |
Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8067766
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Goodman CD et al. |
Chemobiosynthesis of new antimalarial macrolides. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23208707
|
Tomazic J et al. |
In vivo administration of azithromycin affects lymphocyte activity in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239585
|
Kim MK et al. |
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12234843
|
Cantin L and Chamberland S |
In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239619
|
Allen GP and Harris KA |
Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28483960
|
Alder JD et al. |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9736568
|
Carter G et al. |
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561879
|
Gnarpe J et al. |
In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843291
|
Schroeck JL et al. |
Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25870064
|
Nagaoka K et al. |
Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23380724
|
Edelstein PH et al. |
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11451675
|